0001492658-17-000046.txt : 20170907
0001492658-17-000046.hdr.sgml : 20170907
20170907190103
ACCESSION NUMBER: 0001492658-17-000046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170905
FILED AS OF DATE: 20170907
DATE AS OF CHANGE: 20170907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooke Peter
CENTRAL INDEX KEY: 0001577002
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35065
FILM NUMBER: 171074863
MAIL ADDRESS:
STREET 1: 5677 AIRLINE ROAD
CITY: ARLINGTON
STATE: TN
ZIP: 38002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wright Medical Group N.V.
CENTRAL INDEX KEY: 0001492658
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 980509600
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1227
BUSINESS ADDRESS:
STREET 1: PRINS BERNHARDPLEIN 200
CITY: AMSTERDAM
STATE: P7
ZIP: 1097JB
BUSINESS PHONE: 901-867-4317
MAIL ADDRESS:
STREET 1: 1023 CHERRY ROAD
CITY: MEMPHIS
STATE: TN
ZIP: 38117
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier N.V.
DATE OF NAME CHANGE: 20110201
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier B.V.
DATE OF NAME CHANGE: 20100524
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-09-05
0
0001492658
Wright Medical Group N.V.
WNGI
0001577002
Cooke Peter
1023 CHERRY ROAD
MEMPHIS
TN
38117
0
1
0
0
President, International
Ordinary Shares, par value EUR 0.03 per Share
2017-09-05
4
M
0
7875
21.24
A
52488
D
Ordinary Shares, par value EUR 0.03 per share
2017-09-05
4
M
0
29710
20.62
A
82198
D
Ordinary Shares, par value EUR 0.03 per share
2017-09-05
4
M
0
45
20.21
A
82243
D
Ordinary Shares, par value EUR 0.03 per share
2017-09-05
4
S
0
37630
D
44613
D
Ordinary Shares, par value EUR 0.03 per share
2017-09-06
4
M
0
54077
20.21
A
98690
D
Ordinary Shares, par value EUR 0.03 per share
2017-09-06
4
S
0
72131
D
26559
D
Ordinary Shares, par value EUR 0.03 per share
2017-09-07
4
S
0
2934
D
23625
D
Stock Option (right to buy)
21.24
2017-09-05
4
M
0
7875
21.24
D
2026-07-19
Ordinary Shares
7875
21208
D
Stock Option (right to buy)
20.62
2017-09-05
4
M
0
29710
20.62
D
2025-10-13
Ordinary Shares
29710
35160
D
Stock Option (right to buy)
20.21
2017-09-05
4
M
0
45
20.21
D
2023-01-31
Ordinary Shares
45
54077
D
Stock Option (right to buy)
20.21
2017-09-06
4
M
0
54077
20.21
D
2023-01-31
Ordinary Shares
54077
0
D
Includes 18,801 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 4,824 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.15 to $29.58, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.63 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.68 to $29.10 inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
This option vests with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
This option vests with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
These shares vested on October 1, 2015.
/s/Marija Nelson, attorney-in-fact
2017-09-07